Our community has been through a lot over the past two years, and all of us are looking forward to resuming our normal habits and routines. We are excited to see everyone in person at iSRS 2022 in the historical city center of Nantes, France.
The iSRS symposium series has a long and treasured history of providing valued interaction between colleagues throughout the world. Program development is being guided by a team of internationally respected leaders within the field.
This conference aims to address original research in all aspects of radiopharmaceutical science; synthesis, in vitro and ex vivo studies, in vivo biodistribution or imaging, radiopharmacology, radiopharmacy, and translational clinical studies of new targeted radiotracers.
The iSRS 2022 Program Committee and I are pleased to announce that we received over 400 complete abstract submissions. We appreciate all who submitted and regard this as a good number, given current COVID-19 realities.
COVID-19 and iSRS 2022 (the latest information)
French COVID-19 restrictions are being progressively lifted, and the government is talking about the suppression of the vaccination passes by mid-March, if the decrease in the number of cases continues. We are assuming that by May all restrictions will be lifted.
So far, all European citizens can travel within the EU without any restriction. But people must ensure before traveling that they comply with the rules imposed by airline and train companies.
From the French government and updated frequently:
We are very much looking forward to a successful return to an in-person iSRS symposium!
REGISTRATION (early registration ends march 31): here
Stay tuned for iSRS 2022 updates.
iSRS 2022 Program Chair